- Friday 1st of October 2021
Which class of medications does Cenforce 50 belong to?
Cenforce 50 belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. The active ingredient in Cenforce 50 is sildenafil citrate. PDE5 inhibitors are a group of drugs used to treat erectile dysfunction (ED). In the presence of sexual stimulation, nitric oxide is released in the erectile tissue of the penis. Nitric oxide activates an enzyme called guanylate cyclase, leading to an increase in cyclic guanosine monophosphate (cGMP). cGMP relaxes the smooth muscles in the blood vessels of the penis, allowing increased blood flow. This increased blood flow contributes to the ability to achieve and maintain an erection. Phosphodiesterase type 5 is an enzyme that breaks down cGMP. By inhibiting PDE5, medications like Cenforce 50 mg tablet help to maintain higher levels of cGMP in the erectile tissue, promoting vasodilation and improved blood flow to the penis. By enhancing the natural physiological response to sexual stimulation, PDE5 inhibitors assist men with ED in achieving and sustaining erections. It's important to note that Cenforce 50, containing sildenafil citrate, is a generic version of Viagra, which is a well-known brand in the class of PDE5 inhibitors. As with any prescription medication, it should be used under the guidance of a healthcare professional, and individuals should discuss their medical history and any other medications they are taking with their doctor before using Cenforce 50 or similar medications.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply